A phase 2 study of anastrozole in patients with oestrogen receptor and/progesterone receptor positive recurrent/metastatic granulosa cell tumours/sex-cord stromal tumours of the ovary: The PARAGON/ANZGOG 0903 trial

Gynecologic Oncology ◽

10.1016/j.ygyno.2021.07.024 ◽

2021 ◽

Author(s):

Susana N. Banerjee ◽

Monica Tang ◽

Rachel L. O'Connell ◽

Katrin Sjoquist ◽

Andrew R. Clamp ◽

...

Keyword(s):

Progesterone Receptor ◽

Granulosa Cell ◽

Oestrogen Receptor ◽

Phase 2 ◽

Phase 2 Study ◽

Granulosa Cell Tumours ◽

Positive Recurrent

Download Full-text

PARAGON: A phase 2 study of anastrozole (An) in patients with estrogen receptor(ER) and / progesterone receptor (PR) positive recurrent/metastatic granulosa cell tumors/sex-cord stromal tumors (GCT) of the ovary.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.5524 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 5524-5524 ◽

Cited By ~ 3

Author(s):

Susana N. Banerjee ◽

Monica Tang ◽

Rachel O'Connell ◽

Andrew R. Clamp ◽

Rosemary Lord ◽

...

Keyword(s):

Estrogen Receptor ◽

Progesterone Receptor ◽

Granulosa Cell ◽

Phase 2 ◽

Stromal Tumors ◽

Granulosa Cell Tumors ◽

Phase 2 Study ◽

Positive Recurrent ◽

Sex Cord Stromal Tumors

Download Full-text

Phase 2 study of anastrozole in patients with estrogen receptor/progesterone receptor positive recurrent low-grade endometrial stromal sarcomas: The PARAGON trial (ANZGOG 0903)

Gynecologic Oncology ◽

10.1016/j.ygyno.2021.02.016 ◽

2021 ◽

Author(s):

M. Friedlander ◽

C. Benson ◽

R.L. O'Connell ◽

N. Reed ◽

A. Clamp ◽

...

Keyword(s):

Estrogen Receptor ◽

Progesterone Receptor ◽

Low Grade ◽

Phase 2 ◽

Phase 2 Study ◽

Positive Recurrent

Download Full-text

PARAGON (ANZGOG-0903): a phase 2 study of anastrozole in asymptomatic patients with estrogen and progesterone receptor-positive recurrent ovarian cancer and CA125 progression

Journal of Gynecologic Oncology ◽

10.3802/jgo.2019.30.e86 ◽

2019 ◽

Vol 30 (5) ◽

Cited By ~ 3

Author(s):

Peey-Sei Kok ◽

Philip Beale ◽

Rachel L. O'Connell ◽

Peter Grant ◽

Tony Bonaventura ◽

...

Keyword(s):

Ovarian Cancer ◽

Progesterone Receptor ◽

Recurrent Ovarian Cancer ◽

Phase 2 ◽

Asymptomatic Patients ◽

Phase 2 Study ◽

Positive Recurrent ◽

Estrogen And Progesterone Receptor

Download Full-text

Immunohistochemical expression and prognostic significance of oestrogen receptor-alpha, oestrogen receptor-beta, and progesterone receptor in stage 1 adult-type granulosa cell tumour of the ovary

Pathology ◽

10.1097/pat.0b013e328359d636 ◽

2012 ◽

Vol 44 (7) ◽

pp. 611-616 ◽

Cited By ~ 10

Author(s):

S.M. Hutton ◽

L.R. Webster ◽

S. Nielsen ◽

Y. Leung ◽

C.J.R. Stewart

Keyword(s):

Progesterone Receptor ◽

Granulosa Cell ◽

Oestrogen Receptor ◽

Prognostic Significance ◽

Granulosa Cell Tumour ◽

Immunohistochemical Expression ◽

Adult Type ◽

Oestrogen Receptor Alpha ◽

Stage 1 ◽

Receptor Beta

Download Full-text

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study

The Lancet Oncology ◽

10.1016/s1470-2045(14)71159-3 ◽

2015 ◽

Vol 16 (1) ◽

pp. 25-35 ◽

Cited By ~ 947

Author(s):

Richard S Finn ◽

John P Crown ◽

Istvan Lang ◽

Katalin Boer ◽

Igor M Bondarenko ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Oestrogen Receptor ◽

Advanced Breast ◽

Line Treatment ◽

Phase 2 ◽

Cyclin Dependent Kinase ◽

First Line ◽

Phase 2 Study ◽

First Line Treatment

Download Full-text

Loss of oestrogen receptor beta, high PCNA and p53 expression and aneuploidy as markers of worse prognosis in ovarian granulosa cell tumours

Histopathology ◽

10.1046/j.1365-2559.2003.01706.x ◽

2003 ◽

Vol 43 (3) ◽

pp. 254-262 ◽

Cited By ~ 29

Author(s):

S Staibano ◽

R Franco ◽

E Mezza ◽

P Chieffi ◽

A Sinisi ◽

...

Keyword(s):

Granulosa Cell ◽

Oestrogen Receptor ◽

P53 Expression ◽

Ovarian Granulosa Cell ◽

Granulosa Cell Tumours ◽

Worse Prognosis ◽

Receptor Beta

Download Full-text

Phase 2 study of anastrozole in rare cohorts of patients with estrogen receptor/progesterone receptor positive leiomyosarcomas and carcinosarcomas of the uterine corpus: The PARAGON trial (ANZGOG 0903)

Gynecologic Oncology ◽

10.1016/j.ygyno.2021.09.010 ◽

2021 ◽

Author(s):

R.J. Edmondson ◽

R.L. O'Connell ◽

S. Banerjee ◽

L. Mileshkin ◽

P. Sykes ◽

...

Keyword(s):

Estrogen Receptor ◽

Progesterone Receptor ◽

Phase 2 ◽

Uterine Corpus ◽

Phase 2 Study

Download Full-text

Faculty Opinions recommendation of The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725283758.793525555 ◽

2016 ◽

Cited By ~ 1

Author(s):

Daniel Vorobiof

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Oestrogen Receptor ◽

Advanced Breast ◽

Line Treatment ◽

Phase 2 ◽

Cyclin Dependent Kinase ◽

First Line ◽

Phase 2 Study ◽

First Line Treatment

Download Full-text

Ataluren in Patients Aged  2 to < 5 Years with Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD): 28-week Results from a Phase 2 Study

10.1055/s-0039-1698256 ◽

2019 ◽

Author(s):

Christian Werner ◽

Cuixia Tian ◽

Robert Kong ◽

Edward O’Mara ◽

Traci Schilling ◽

...

Keyword(s):

Duchenne Muscular Dystrophy ◽

Muscular Dystrophy ◽

Nonsense Mutation ◽

Phase 2 ◽

Phase 2 Study

Download Full-text

NEAR-INFRARED FLUORESCENCE MOLECULAR ENDOSCOPY SHOWS PROMISING RESULTS IN DETECTING DYSPLASTIC ESOPHAGEAL LESIONS USING TOPICALLY ADMINISTERED BEVACIZUMAB-800CW: THE PRELIMINARY RESULTS OF A PHASE 2 STUDY

10.1055/s-0040-1704289 ◽

2020 ◽

Author(s):

RY Gabriëls ◽

WTR Hooghiemstra ◽

I Schmidt ◽

JJH van der Laan ◽

G Kats-Ugurlu ◽

...

Keyword(s):

Near Infrared ◽

Phase 2 ◽

Near Infrared Fluorescence ◽

Preliminary Results ◽

Phase 2 Study

Download Full-text